Intended for overactive bladder to manage urinary urgency and support improved bladder capacity.
Mechanism of Action
Darifenacin is a selective M3 muscarinic receptor antagonist. It blocks the receptors on the detrusor muscle, reducing involuntary contractions and alleviating the frequent urge to urinate.
Route of Administration
Oral
Onset Time
2 weeks
Duration
24 hours
Contraindications
Urinary retention, Gastric retention, Uncontrolled narrow-angle glaucoma, Severe hepatic impairment
Severe Adverse Events
Angioedema, Tachycardia, Confusion — requires immediate medical attention
Information related to Enablex is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
